Andreas Arnold-Vangsted

Dr. Andreas Arnold-Vangsted

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2026 in Graefe's Archive for Clinical and Experimental Ophthalmology
Verified
Journal Article
Closed access
PDF file
DBDaniel Balsby
Daniel Balsby
AAAndreas Arnold-Vangsted
Andreas Arnold-Vangsted
EREmil Alexander Rosenørn
Emil Alexander Rosenørn
NENathalie Skovgaard Eriksen
Nathalie Skovgaard Eriksen
HAHassan Javed Ahmed
Hassan Javed Ahmed
MSMiklos Schneider
Miklos Schneider

1 April 2026 in AJO International
Verified
Journal Article
Open access
PJPeter Elmegaard Junior
Peter Elmegaard Junior
VCVibeke Christensen
Vibeke Christensen
MRMaja Elise Sigaard Ravn
Maja Elise Sigaard Ravn
LBLars Christian Boberg-Ans
Lars Christian Boberg-Ans
KPKristina Pfau
Kristina Pfau
AAAndreas Arnold-Vangsted
Andreas Arnold-Vangsted

20 January 2026 in AJO International
Verified
Journal Article
Open access
VCVibeke Rugaard Christensen
Vibeke Rugaard Christensen
LBLars Christian Boberg-Ans
Lars Christian Boberg-Ans
PJPeter Elmegaard Junior
Peter Elmegaard Junior
LCLasse Jørgensen Cehofski
Lasse Jørgensen Cehofski
JGJakob Grauslund
Jakob Grauslund
AAAndreas Arnold-Vangsted
Andreas Arnold-Vangsted

8 July 2025 in American Journal of Ophthalmology Case Reports
Verified
Journal Article
Open access
AAAndreas Arnold-Vangsted
Andreas Arnold-Vangsted
TITomas Ilginis
Tomas Ilginis
JKJens F. Kiilgaard
Jens F. Kiilgaard
SHSteffen Heegaard
Steffen Heegaard
CFCarsten Faber
Carsten Faber
To describe a case of vitreoretinal lymphoma with unilateral vascular involvement. A 80-year-old male with recurrent amaurosis fugax (AF) in the left eye was seen in the ophthalmological department. During a period of seven months the patient developed central vein occlusion (CRVO) and later the panuveitis suspected to be acute retinal necrosis (ARN) before being diagnosed with vitreoretinal lymphoma (VRL). The patient preferred enucleation as treatment which allowed thorough histological examination revealing Epstein Barr virus-associated vitreoretinal lymphoma. Vascular involvement with AF and CRVO is yet to be described in relation to VRL. This case-study underlines the critical importance of considering VRL when the clinical course deviates from the expected.